Literature DB >> 25133155

Rare large homozygous CFTR gene deletion in an Iranian patient with cystic fibrosis.

Shirin Farjadian1, Mozhgan Moghtaderi1, Roberta Zuntini1, Simona Ferrari1.   

Abstract

Cystic fibrosis, a common autosomal recessive genetic disorder among Caucasians, is caused by defects in the transmembrane conductance regulatory (CFTR) gene. The analysis of CFTR gene mutations is useful to better characterize the disease, and for preconceptional screening, prenatal and preimplantation genetic diagnosis. Here we report the results of a genetic analysis in a 16-year-old boy from southwestern Iran diagnosed as having cystic fibrosis in infancy based on gastrointestinal and pulmonary manifestations, with positive sweat chloride tests. He lacked both normal and mutant forms of the fragment corresponding to the ∆F508 allele in initial genetic studies. Multiplex ligation-dependent probe amplification-based testing revealed a homozygous deletion spanning exons 4 to 10 of the CFTR gene. We predict an in-frame deletion removing 373 amino acids based on our sequencing results. Determining CFTR gene mutations in patients and their family members would be helpful to prevent the occurrence of new cases, especially in populations in which consanguinity is common.

Entities:  

Keywords:  Cystic fibrosis; Homozygous deletion; Transmembrane conductance regulatory gene

Year:  2014        PMID: 25133155      PMCID: PMC4133434          DOI: 10.12998/wjcc.v2.i8.395

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  6 in total

1.  40 kilobase deletion (CF 40 kb del 4-10) removes exons 4 to 10 of the Cystic Fibrosis Transmembrane Conductance Regulator gene.

Authors:  F Chevalier-Porst; A M Bonardot; J P Chazalette; M Mathieu; D Bozon
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

Review 2.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

Review 3.  PGD for cystic fibrosis patients and couples at risk of an additional genetic disorder combined with 24-chromosome aneuploidy testing.

Authors:  Svetlana Rechitsky; Oleg Verlinsky; Anver Kuliev
Journal:  Reprod Biomed Online       Date:  2013-01-29       Impact factor: 3.828

4.  Characterization of CFTR expression and chloride channel activity in human endothelia.

Authors:  A Tousson; B A Van Tine; A P Naren; G M Shaw; L M Schwiebert
Journal:  Am J Physiol       Date:  1998-12

5.  Apparent homozygosity of a novel frame shift mutation in the CFTR gene because of a large deletion.

Authors:  Feras M Hantash; Arlene Rebuyon; Mei Peng; Joy B Redman; Weimin Sun; Charles M Strom
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

6.  Clinical and genetic features in patients with cystic fibrosis in southwestern iran.

Authors:  Shirin Farjadian; Mozhgan Moghtaderi; Sara Kashef; Soheila Alyasin; Khadijehsadat Najib; Forough Saki
Journal:  Iran J Pediatr       Date:  2013-04       Impact factor: 0.364

  6 in total
  1 in total

1.  Reappraisal of Frequency of Common Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations in Iranian Cystic Fibrosis Patients.

Authors:  Soheila Khalilzadeh; Maryam Hassanzad; Mihan PourAbdollah Toutkaboni; Sabereh Tashayoie Nejad; Fatemeh-Maryam Sheikholeslami; Ali Akbar Velayati
Journal:  Tanaffos       Date:  2018-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.